Côd QR

Combined radiation and immune checkpoint inhibitor therapy for metastatic or recurrent hepatocellular carcinoma: a real-world study of 108 patients

BackgroundThe prognosis of metastatic or recurrent hepatocellular carcinoma (HCC) remains poor, and new treatment strategies are warranted. Despite promising preclinical results demonstrating that radiation primes the immune system and produces a synergistic antitumor response for long-term disease...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Yirui Zhai, Yefan Zhang, Fan Wu, Jianguo Zhou, Lingxia Xin, Feng Ye, Wei Sun, Huiying Zeng, Yan Song, Yongkun Sun, Wen Zhang, Shu-Lian Wang, Yuan Tang, Hui Fang, Pan Zhao, Yueping Liu, Ningning Lu, Shunan Qi, Hao Jing, Wenwen Zhang, Yongwen Song, Ye-Xiong Li, Liming Wang, Bo Chen
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Frontiers Media S.A. 2025-08-01
Cyfres:Frontiers in Immunology
Pynciau:
hepatocellular carcinoma
radiotherapy
immunotherapy
immune checkpoint inhibitor
PD-1/PD-L1 inhibitor
Mynediad Ar-lein:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1594577/full
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg